“biomarin-pharmaceutical” Archives

in
Entry Author Date Location
Gene Therapy Firms Seek Clarity on FDA Exclusivity, Orphan Designations 09/22/20 National
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
FDA Rejects BioMarin Hemophilia Gene Therapy, Asks for More Data 08/19/20 National
CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy 06/25/20 Philadelphia
Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact 06/01/20 New York
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
PTC Therapeutics to Acquire Censa Pharma for Mid-Stage Rare Disease Drug 05/07/20 New York
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans 01/13/20 Boston
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More 12/20/19 National
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More 10/11/19 National
Amicus Offers First Look At Gene Therapy Work With Batten’s Data 08/01/19 New York
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
With Sliver of Data, BioMarin to Seek OK for Hemophilia Gene Therapy 05/28/19 San Francisco
After AGTC Deal Flops, Biogen Bets $800M on Gene Therapy Rival Nightstar 03/04/19 Boston
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
Data Starts Stretch Run for UniQure’s Upgraded Hemophilia Gene Therapy 11/15/18 Boston
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom 10/04/18 San Francisco
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More 08/10/18 National
Bio Roundup: Brii Does China, Hemophilia Updates, Right to Try & More 05/25/18 National
Data Could Make Roche Drug a Hemophilia Standard, But for How Long? 05/21/18 San Francisco
Gene Therapy 2.0: New Startups Aim to Fine-Tune Gene Delivery and Control 01/04/18 Boston
In Week of Hemophilia News, Alnylam Drug Cleared to Move Forward 12/15/17 Boston
Gene Therapy Advances, But Hemophilia Is No Easy Target 12/13/17 National
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
UniQure to Yank Pioneering Gene Therapy From Market in Europe 04/20/17 Boston
Investors Sour on Data Debut For Dimension’s Hemophilia Gene Therapy 01/31/17 Boston
Page 1 of 4 next page »